Supplementary Figure S2 from Validation of a Seven-Gene Predictive SIGNature for the Efficacy of Immuno-Oncology PD-1 Inhibitors in Patients with Sarcoma

Read full text Summarise with VIRAT
Authors: David S. Moura, Jesus Lopez-Marti, Hussein A. Tawbi, Emily Zhi-Yun Keung, Khalida Wani, Alexander J. Lazar, Wei‐Lien Wang, Davis R. Ingram, Leonardo A. Meza‐Zepeda, Ola Myklebost, Melissa Amber Burgess, Jose Lucinio Mondaza-Hernandez
+2 more Nadia Hindi, Javier Martín-Broto
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Supplementary Figure S2. Progression-free survival probability of the patients treated within the GEIS-32 clinical trial, according to the 7 gene-based score. Time is defined in months.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Sarcoma Diagnosis and Treatment Lymphoma Diagnosis and Treatment

Publication details

Publication date
1 April 2026
Language
EN